Royalty Pharma Plc(RPRX)— 技术面状态
数据截至2026-09-23 — 每个交易日晚间对全部覆盖范围重新计算。Closelook研究日记,不构成投资建议。
Trades -2.9% vs the 50-day and +14.8% vs the 200-day average, 10.5% below the 52-week high and +69% off the 52-week low. Computed from daily closes.
均线状态
- 相对20日均线-4.4%
- 相对50日均线-2.9%
- 相对200日均线+14.8%
- 52周区间低于52周高点10.5% · 高于52周低点69%
- 连续走势连续1个交易日下跌
- 50日均线交叉股价向下穿越50日均线(9个交易日前)
- 随机指标%K 0.1 · %D 10.7
FAQ · from the current data · as of 2026-09-23
Quick answers
RPRX当前的Closelook信号是什么?
Pullback inside an uptrend stack — Trades -2.9% vs the 50-day and +14.8% vs the 200-day average, 10.5% below the 52-week high and +69% off the 52-week low. Computed from daily closes.(截至2026-09-23;信号看板每个交易日晚间对全部覆盖范围重新计算。研究日记读数,不构成投资建议。)
RPRX目前是否位于50日和200日均线上方?
截至2026-09-23,Royalty Pharma Plc位于50日均线下方(-2.9%),200日均线上方(+14.8%);距20日均线-4.4%。
RPRX距52周高点有多远?
截至2026-09-23,低于52周高点10.5%,高于52周低点69%。
Related in the Closelook universe
then Biotechnology. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- BION.SW BB Biotech AGindustry
- ARGX.BR Argen-Xindustry
- ARGX argenx NV ADRindustry
- ONC BeiGene, Ltd.industry
- CAI Caris Life Sciences, Inc. Common Stockindustry
- REGN Regeneron Pharmaceuticals Incindustry
- MRNA Moderna Incindustry
- TWST Twist Bioscience Corpindustry
- ONT.L Oxford Nanopore Technologies Ltdindustry
- VKTX Viking Therapeutics Incindustry
- HALO Halozyme Therapeutics Incindustry
- DNA Ginkgo Bioworks Holdingsindustry
- RXRX Recursion Pharmaceuticals Incindustry
- SMMT Summit Therapeutics PLCindustry
- IBRX Immunitybio Incindustry
- GMAB Genmab ASindustry
- MRVI Maravai Lifesciences Holdings Incindustry
- TGTX TG Therapeutics Incindustry
- CRSP Crispr Therapeutics AGindustry
- EXEL Exelixis Incindustry